You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent glioblastomas

Showing 1 - 25 of 7,807
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma Trial in Beijing (Laser interstitial thermal therapy, Temozolomide)

Active, not recruiting
  • Recurrent Glioblastoma
  • Beijing, China
    Beijing Tiantan Hospital
Dec 22, 2022

Recurrent Glioblastoma Trial in Beijing (Combined stereotactic radiosurgery and enhanced immunotherapy)

Recruiting
  • Recurrent Glioblastoma
  • Combined stereotactic radiosurgery and enhanced immunotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Nov 16, 2021

Glioblastoma Trial in Beijing (B7-H3-targeting CAR-T cells)

Recruiting
  • Glioblastoma
  • B7-H3-targeting CAR-T cells
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Feb 11, 2022

Anti-angiogenic Treatment in Recurrent Glioblastoma

Recruiting
  • Adult Glioblastoma
  • +2 more
  • 3-Tesla conventional magnetic resonance imaging
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Feb 6, 2020

Glioblastoma, Recurrent Glioblastoma, GBM Trial in Santa Monica (Radiation: Intra-operative Radiation Therapy - IORT,

Recruiting
  • Glioblastoma
  • +3 more
  • Radiation: Intra-operative Radiation Therapy - IORT
  • +2 more
  • Santa Monica, California
    Providence Saint John's Health Center
Jul 14, 2022

Recurrent Glioblastoma Trial in Shanghai (Camrelizumab plus GSC-DCV, Camrelizumab plus Placebo)

Recruiting
  • Recurrent Glioblastoma
  • Camrelizumab plus GSC-DCV
  • Camrelizumab plus Placebo
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Nov 28, 2021

Recurrent Glioblastoma, Glioblastoma - Category Trial in Edmonton (Repeat Surgical Management of Recurrent GBM)

Recruiting
  • Recurrent Glioblastoma
  • Glioblastoma - Category
  • Repeat Surgical Management of Recurrent GBM
  • Edmonton, Alberta, Canada
    University of Alberta Division of Neurosurgery
Apr 5, 2022

Glioblastoma Trial in Germany (iMRI-guided surgery, 5-ALA-guided surgery)

Completed
  • Glioblastoma
  • iMRI-guided surgery
  • 5-ALA-guided surgery
  • Bonn, Germany
  • +14 more
Oct 21, 2021

Recurrent Glioblastoma Multiforme Trial in Sao Paulo (Stereotactic hypofractionated RT 5x5Gy, Stereotactic hypofractionated RT

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • Stereotactic hypofractionated RT 5x5Gy
  • Stereotactic hypofractionated RT 5x7Gy
  • Sao Paulo, SP, Brazil
    Hospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021

Glioblastoma, GBM, Recurrent GBM Trial in Chattanooga (Intra-operative Radiation Therapy - IORT)

Recruiting
  • Glioblastoma
  • +2 more
  • Intra-operative Radiation Therapy - IORT
  • Chattanooga, Tennessee
    Southeastern Spine Neurosurgery
Mar 5, 2021

Gliomas Trial in Miami, Boston, New York (Nivolumab)

Active, not recruiting
  • Gliomas
  • Miami, Florida
  • +3 more
May 5, 2022

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Glioblastoma, Adult Trial in Rennes (Fluorescéine Sodique Faure, White-light surgery)

Completed
  • Glioblastoma, Adult
  • Fluorescéine Sodique Faure
  • White-light surgery
  • Rennes, France
    CHU Rennes
Nov 8, 2022

Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)

Not yet recruiting
  • Glioblastoma
  • Amyvid, Intravenous Solution
  • Bayamon, Puerto Rico
  • +1 more
Apr 18, 2023

Recurrent High-grade Glioma Trial in Hangzhou (Anlotinib HCl)

Recruiting
  • Recurrent High-grade Glioma
  • Anlotinib hydrochloride
  • Hangzhou, China
    Hangzhou Cancer Hospital
Mar 26, 2021

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

Completed
Has Results
  • Adult Anaplastic Astrocytoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 28, 2021

Circulating and Tumor-infiltrating Immune Cells in Malignant

Recruiting
  • Brain Tumor, Primary
  • Brain Tumor - Metastatic
  • Circulating leukocytes immunophenotype
  • Tumor sampling
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Apr 14, 2023

Glioblastomas Trial in BRON Cedex, Lyon (Feasibility study for the realization of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT for

Recruiting
  • Glioblastomas
  • Feasibility study for the realization of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT for identification of early recurrence in patients treated with radiotherapy for glioblastoma.
  • BRON Cedex, France
  • +1 more
Oct 9, 2020

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Glioblastoma Trial in Worldwide (Surgery followed by adjuvant second-line therapy, Second-line therapy alone)

Recruiting
  • Glioblastoma
  • Surgery followed by adjuvant second-line therapy
  • Second-line therapy alone
  • Innsbruck, Austria
  • +21 more
May 10, 2022

Using Genomic, Histologic and Radiomic Analysis to Evaluate

Suspended
  • Glioblastoma
  • Tumor Biopsy
  • Ann Arbor, Michigan
    University of Michigan
Oct 6, 2022

Invasive Margin of Glioblastomas (PRaM-GBM Study)

Active, not recruiting
  • High Grade Glioma
  • Diffusion tensor Imaging (DTI)
  • Cambridge, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Dec 29, 2021

An Integrated Radio-immunological Approach

Recruiting
  • Glioma, Malignant
    • Florence, Italy
    • +1 more
    Mar 23, 2022

    Exploration of Locally Recurrent Colorectal Cancer

    Recruiting
    • Locally Recurrent Colorectal Cancer
    • salvage surgery
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences & Peking Un
    Oct 28, 2023

    Glioblastoma Trial in Sacramento (Biospecimen Collection, Lidocaine, Resection)

    Active, not recruiting
    • Glioblastoma
    • Biospecimen Collection
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jan 21, 2022